← Leaderboards
Teresa G Hastings
University Of Pittsburgh At Pittsburgh
$5,665,601
Attributed
$5,665,601
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $909K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$5,665,601 · 5
By mechanism
R01$3,545,115 · 3
P01$2,120,486 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Michael J Zigmond$14,942,841
- Charleen T Chu$13,687,402
- Amanda D Smith$1,399,449
- Jane E Cavanaugh$991,004
- Susan R Sesack$4,604,811
Others in their field
Top investigators on “Dopamine”
- Pedro A. Jose · George Washington University$34,248,029
- Jonathan A Javitch · Columbia University Health Sciences$28,566,988
- Michael A Nader · Emory University$26,344,520
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,527,588
- Michael A Schwarzschild · Massachusetts General Hospital$22,973,787
- David Sulzer · Columbia University Health Sciences$22,837,505
Research focus
DopamineOxidative StressLaboratory RatTissue /Cell CultureCell DeathNeurotoxinsNeuronsNeural DegenerationMitochondriaCell Component Structure /FunctionCorpus StriatumOxidationNeurotransmitter MetabolismParkinson'S DiseaseSubstantia NigraMitochondrial Disease /DisorderMembrane PotentialsNeuropathologyBioenergetics6 HydroxydopamineCardiolipinsAutopsyDisorder ControlDopaminergic Cell
Grant awards (21)
Mitochondrial Selenoproteins in Parkinson's Disease$363,714
P01 · FY2013 · NS · contact PI
Mitochondrial Selenoproteins in Parkinson's Disease$257,059
P01 · FY2012 · NS · contact PI
Mitochondrial Selenoproteins in Parkinson's Disease$253,229
P01 · FY2011 · NS · contact PI
Mitochondrial Selenoproteins in Parkinson's Disease$252,845
P01 · FY2010 · NS · contact PI
Mitochondrial Selenoproteins in Parkinson's Disease$249,975
P01 · FY2009 · NS · contact PI
Dopamine Toxicity and Mitochondrial Dysfunction$299,128
R01 · FY2006 · NS · contact PI
Control of neuronal ROS generation by membrane potential$350,942
R01 · FY2005 · AG
Dopamine Toxicity and Mitochondrial Dysfunction$306,649
R01 · FY2005 · NS
MITOCHONDRIAL DYSFUNCTION AND METHAMPHETAMINE TOXICITY$251,388
R01 · FY2005 · DA
Control of neuronal ROS generation by membrane potential$418,435
R01 · FY2004 · AG
Dopamine Toxicity and Mitochondrial Dysfunction$306,963
R01 · FY2004 · NS
MITOCHONDRIAL DYSFUNCTION AND METHAMPHETAMINE TOXICITY$252,068
R01 · FY2004 · DA
Dopamine Toxicity and Mitochondrial Dysfunction$308,232
R01 · FY2003 · NS
MITOCHONDRIAL DYSFUNCTION AND METHAMPHETAMINE TOXICITY$253,138
R01 · FY2003 · DA
Dopamine Toxicity and Mitochondrial Dysfunction$301,457
R01 · FY2002 · NS
MITOCHONDRIAL DYSFUNCTION AND METHAMPHETAMINE TOXICITY$254,204
R01 · FY2002 · DA
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS$207,281
P01 · FY2002 · NS
MITOCHONDRIAL DYSFUNCTION AND METHAMPHETAMINE TOXICITY$242,511
R01 · FY2001 · DA
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS$207,281
P01 · FY2001 · NS
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS$207,281
P01 · FY2000 · NS
DOPAMINE REGULATION IN THE SELECTIVE VULNERABILITY OF DOPAMINERGIC NEURONS$121,821
P01 · FY2000 · NS